batch-to-batch variation, contamination with pathogens or lead/arsenic, product- product variability users assume is uniform (but can be diverse within a supply chain), herb-drug interactions like modulating CYP enzymes that change the pharmacokinetics of drugs with narrow therapeutic windows all contribute to problems related to reproducibility and safety (195)
[DOI] [PubMed] [Google Scholar] 110.Pappas PG, Kauffman CA, Andes D, Benjamin DK, Jr, Calandra TF, Edwards JE, Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD, Infectious Diseases Society of A Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America
For gut health specifically, it brings a set of capabilities that no anti-inflammatory agent alone can replicate: it physically repairs damaged tissue
However, its essential to consult with Dr